Awareness and acceptance of HPV vaccination for condyloma acuminata among men who have sex with men in China

References

• Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24:1–7.
   PubMed Web of Science ®Google Scholar
• Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39.
   PubMed Web of Science ®Google Scholar
• Jin F, Prestage GP, Kippax SC, Pell CM, Donovan B, Templeton DJ, Kaldor JM, Grulich AE. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis. 2007;34:488–493.
   PubMed Web of Science ®Google Scholar
• Banura C, Mirembe FM, Orem J, Mbonye AK, Kasasa S, Mbidde EK. Prevalence, incidence and risk factors for anogenital warts in sub Saharan Africa: a systematic review and meta analysis. Infect Agent Cancer. 2013;8:27.
   PubMed Web of Science ®Google Scholar
• Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13(5):487–500.
   PubMed Web of Science ®Google Scholar
• Wei F, Guo M, Huang S, Li M, Cui X, Su Y, et al. Sex differences in the Incidence and clearance of anogenital human papillomavirus infection in Liuzhou, China: an observational cohort study. Clin Infect Dis. 2020;70(1):82–89.
   PubMed Web of Science ®Google Scholar
• Nordenvall C, Chang ET, Adami HO, Ye W. Cancer risk among patients with condylomata acuminata. Int J Cancer. 2006;119:888–893.
   PubMed Web of Science ®Google Scholar
• Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer: A Danish study of nearly 50 000 patients with genital warts. J Infect Dis. 2012;205:1544–1553.
   PubMed Web of Science ®Google Scholar
• Li YZ, Xu JJ, Qian HZ, You BX, Zhang J, Zhang JM, Hu QH, Chu ZX, Liu SY, Jiang YJ, et al. High prevalence of HIV infection and unprotected anal intercourse among older men who have sex with men in China: a systematic review and meta-analysis. BMC Infect Dis. 2014;14(1):531.
   PubMedGoogle Scholar
• Geretti AM, Brook G, Cameron C, Chadwick D, French N, Heyderman R, Ho A, Hunter M, Ladhani S, Lawton M, et al. British HIV association guidelines on the use of vaccines in HIV-positive adults 2015. HIV Med. 2016;17(Suppl 3):s2–s81.
   PubMed Web of Science ®Google Scholar
• Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Bmj. 2013;346:f2032.
   PubMed Web of Science ®Google Scholar
• Petrosky E, Bocchini JAsJr., Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–304.
   PubMed Web of Science ®Google Scholar
• Human papillomavirus vaccines: WHO position paper , May 2017. Releve epidemiologique hebdomadaire. World Health Organ. 2017;92:241–268. doi:10.1016/j.vaccine.2017.05.069.
   Google Scholar
• World Health Organization. Vaccine in national immunization programme update[EB/OL]. [2021-03-08]. http://www.who.int/immunization/monitoring_surveillance/VaccineIntroStatus.pptx?ua=1.
   Google Scholar
• Mo ZJ, Bi ZF, Sheng W, Chen Q, Huang T, Li MQ, et al. Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: a dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial. Hum Vaccines Immuno. 2022;2092363.
   PubMed Web of Science ®Google Scholar
• Li X, Cao X, Li Z, Yang Y, Li M, Feng B, Xin H, Zhang H, Gao L. Human papillomavirus awareness and vaccine acceptability among men who have sex with men from mainland China. Sci Rep. 2019;9:8763.
   PubMed Web of Science ®Google Scholar
• Tian T, Wang D, Papamichael C, Yan Z, Guoyao S, Zhanlin Z, Mahan Y, Xiaoqing T, Zheng G, Jianghong D, et al. HPV vaccination acceptability among men who have sex with men in Urumqi, China. Hum Vaccines Immuno. 2019;15(4):1005–1012.
   PubMed Web of Science ®Google Scholar
• Zou H, Meng X, Jia T, Zhu C, Chen X, Li X, Xu J, Ma W, Zhang X. Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: a cross-sectional study. Hum Vaccin Immunother. 2016;12:1551–1559.
   PubMed Web of Science ®Google Scholar
• Lau JT, Wang Z, Kim JH, Lau M, Lai CH, Mo PK, Gray CM. Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among men who have sex with men in Hong Kong. PLoS One. 2013;8:e57204.
   PubMed Web of Science ®Google Scholar
• Wang Z, Mo PK, Lau JT, Lau M, Lai CH. Acceptability of HPV vaccines and perceptions related to genital warts and penile/anal cancers among men who have sex with men in Hong Kong. Vaccine. 2013;31:4675–4681.
   PubMed Web of Science ®Google Scholar
• He W, Pan H, Lin B, Zhong X. Analysis of HPV vaccination willingness amongst HIV-negative men who have sex with men in China. Vaccines (Basel). 2021;24(9):1069.
   Web of Science ®Google Scholar
• Pan H, He W, Lin B, Zhong X. Factors influencing HPV vaccination willingness among men who have sex with men in China: a structural equation modeling analysis. Hum Vaccines & Immuno. 2022;18:2038504.
   PubMed Web of Science ®Google Scholar
• Dong MJ, Peng B, Liu ZF, Ye QN, Liu H, Lu XL, Zhang B, Chen JJ. The prevalence of HIV among MSM in China: a large-scale systematic analysis. BMC Infect Dis. 2019;19:1000.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lin YF, Gao L, Dai J, Luo G, Li L, Yuan T, Li P, Zhan Y, Gao Y, et al. Human papillomavirus prevalence among men who have sex with men in China: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2021;40(7):1357–1367.
   PubMed Web of Science ®Google Scholar
• van der Loeff MF, Nyitray AG, Giuliano AR. HPV vaccination to prevent HIV infection: time for randomized controlled trials. Sex Transm Dis. 2011;38:640–643.
   PubMed Web of Science ®Google Scholar
• Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD. Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect. 2014;90:515–523.
   PubMed Web of Science ®Google Scholar
• Reiter PL, Brewer NT, McRee AL, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis. 2010;37:197–203.
   PubMed Web of Science ®Google Scholar
• Gichane MW, Calo WA, McCarthy SH, Walmer KA, Boggan JC, Brewer NT. Human papillomavirus awareness in Haiti: preparing for a national HPV vaccination program. J Pediatr Adolesc Gynecol. 2017;30:96–101.
   PubMed Web of Science ®Google Scholar
• Lieber M, Reynolds CW, Lieb W, McGill S, Beddoe AM. Human papillomavirus knowledge, attitudes, practices, and prevalence among men who have sex with men in Monrovia, Liberia. J Low Genit Tract Dis. 2018;22:326–332.
   PubMed Web of Science ®Google Scholar
• Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, Richardson D, Marlow LAV, Smith H, Jones CJ, et al. Vaccine acceptability, uptake and completion amongst men who have sex with men: a systematic review, meta-analysis and theoretical framework. Vaccine. 2021;39(27):3565–3581.
   PubMed Web of Science ®Google Scholar
• Gerend MA, Madkins K, Phillips G, Mustanski B. Predictors of human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2016;43:185–191.
   PubMed Web of Science ®Google Scholar
• Rank C, Gilbert M, Ogilvie G, Jayaraman GC, Marchand R, Trussler T, Hogg RS, Gustafson R, Wong T. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs. Vaccine. 2012;30:5755–5760.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xin X, Deng H, Xu J, Weng W, Zhang M, Li J, Gao Y, Huang X, Liu C, et al. Improving the acceptability of human papillomavirus vaccines among men who have sex with men according to the associated factors: a systematic review and meta-analysis. Front Pharmacol. 2021;12:600273.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136:2752–2760.
   PubMed Web of Science ®Google Scholar
• Bruni L, Saura-Lazaro A, Montoliu A, Brotons M, Alemany L, Diallo MS, Afsar OZ, LaMontagne DS, Mosina L, Contreras M, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Prev Med. 2021;144:106399.
   PubMed Web of Science ®Google Scholar